Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №6 (2025) > The role of CD14 in the pathogenesis of rheumatoid arthritis

The role of CD14 in the pathogenesis of rheumatoid arthritis

Vitaly B. Kaliberdenko , Andrey V. Petrov , Alexander A. Gorlov , Emiliya R. Zagidullina , Tatiana S. Pronkina , Ekaterina S. Gorbenko , Darya I. Bachalova , Amina I. Batkaeva

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Objective. To identify a possible correlation between the concentration of sCD14 and the severity of rheumatoid arthritis, to determine its role in the pathological process. 
Material and methods. The literature review includes an analysis of scientific papers from the databases PubMed, MEDLINE, Embase, eLibrary, CyberLeninka and GoogleScholars. 
Conclusion. CD14 performs several important and potentially different biological functions, including endotoxin binding, mediation of cellular apoptosis, as well as regulation of lymphocyte activation and function, and acts as an acute phase protein. sCD14 may serve as a potential "link" explaining the increased risk of cardiovascular disease observed in patients with rheumatoid arthritis. 
Keywords: rheumatoid arthritis, CD14, monocytes.

About the Author

Vitaly B. Kaliberdenko 1 , Andrey V. Petrov 1 , Alexander A. Gorlov 1 , Emiliya R. Zagidullina 1 , Tatiana S. Pronkina 1 , Ekaterina S. Gorbenko 1 , Darya I. Bachalova 1 , Amina I. Batkaeva 2

1 Georgievsky Order of the Red Banner Medical Institute (structural division), Vernadsky Crimean Federal University, Simferopol, Russia;

2 Saint Petersburg State Pediatric Medical University, St. Petersburg, Russia

References

1. Doan T, Massarotti E. Rheumatoid arthritis: An overview of new and emerging therapies. J Clin Pharmacol 2005;45:751-62. DOI: 10.1177/0091270005277938 
2. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19. DOI: 10.1056/NEJMra1004965 
3. Furukawa S, Hirano R, Sugawara A et al. Serum-free Quality and Quantity Control Culture Improves the Angiogenic Potential of Peripheral Blood Mononuclear Cells Harvested from Patients with Connective Tissue Diseases. Journal of Plastic and Reconstructive Surgery 2024;3(4):157-64. DOI: 10.53045/jprs.2022-0050 
4. Yennemadi AS, Jordan N, Diong S et al. The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases. The Journal of Rheumatology 2024;51(3):234-41. DOI: 10.3899/jrheum.2023-0833 
5. Radushev V, Karkossa I, Berg J et al. Dysregulated cytokine and oxidative response in hyper-glycolytic monocytes in obesity. Frontiers in Immunology 2024;15. DOI: 10.3389/fimmu.2024.1416543 
6. Malik AE, Slauenwhite D, McAlpine SM et al. Differences in IDO1+ dendritic cells and soluble CTLA-4 are associated with differential clinical responses to methotrexate treatment in rheumatoid arthritis. Frontiers in Immunology 2024;15. DOI: 10.3389/fimmu.2024.1352251 
7. Скогорева Н.В., Макеева А.В. Патофизиологическая характеристика ревматоидного артрита: этиология, патогенез и принципы лечения. Международный студенческий научный вестник. 2015;(2):118-9. Skogoreva N.V., Makeeva A.V. Pathophysiological characteristics of rheumatoid arthritis: etiology, pathogenesis and principles of treatment. International Student Scientific Bulletin. 2015;(2):118-9 (in Russian). 
8. Федорова М.Г., Комарова Е.В., Белков А.Р., Мишин В.А. Аспекты этиологии, патогенеза и морфологии ревматоидного артрита (обзор литературы). Известия высших учебных заведений. Поволжский регион. Медицинские науки. 2024;(2):152-66. DOI: 10.21685/2072-3032-2024-2-14 Fedorova M.G., Komarova E.V., Belkov A.R., Mishin V.A. Aspects of etiology, pathogenesis and morphology of rheumatoid arthritis (literature review). News of higher educational institutions. The Volga region. Medical sciences. 2024;(2):152-66. DOI: 10.21685/2072-3032-2024-2-14 (in Russian). 
9. Арлеевская М.И., Зинкевич О.Д., Воронина И.Е. Функциональное состояние нейтрофилов и моноцитов при ревматоидном артрите. Казанский медицинский журнал. 2017;(5):362-4. Arleevskaya M.I., Zinkevich O.D., Voronina I.E. Functional state of neutrophils and monocytes in rheumatoid arthritis. Kazan Medical Journal. 2017;(5):362-4 (in Russian). 
10. Trudy McGarry, Megan M. Hanlon, Viviana Marzaioli et al. Rheumatoid arthritis CD14+ monocytes display metabolicand inflammatory dysfunction, a phenotype that precedesclinical manifestation of disease. Clinical & Translational Immunology 2021;e1237. DOI: 10.1002/cti2.1237 11. Hasheminasab SS, Conejeros I, Gärtner U et al. MCT-Dependent Cryptosporidium parvum-Induced Bovine Monocyte Extracellular Traps (METs) under Physioxia. Biology 2023;12(7):961. DOI: 10.3390/biology12070961 
12. Malmhäll-Bah E, Andersson KME, Erlandsson MC et al. Metabolic signature and proteasome activity controls synovial migration of CDC42hiCD14+ cells in rheumatoid arthritis. Frontiers in Immunology 2023;14. DOI:10.3389/fimmu.2023.1187093 
13. Pucino V, Nefla M, Gauthier V et al. Buckley, Differential effect of lactate on synovial fibroblast and macrophage effector functions. Frontiers in Immunology 2023;14. DOI:10.3389/fimmu.2023.1183825 
14. Peng Q, Wang J, Han M et al. Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation. Chinese Medicine 2023;18(1). DOI: 10.1186/s13020-023-00765-1 
15. Huang QQ, Pope RM. The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 2009;11:357-64. DOI: 10.1007/s11926-009-0051-z 
16. Pugin J, Heumann ID, Tomasz A et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-16. DOI: 10.1016/1074-7613(94)90093-0 17. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005;11:225-9. DOI: 10.1179/096805105X46565 
18. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004;172:4470-9. 
19. Horneff G, Sack U, Kalden JR et al. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993;91:207-13. DOI: 10.1111/j.1365-2249.1993.tb05884.x 
20. Yu S, Nakashima N, Xu BH et al. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 1998;17:237-43. DOI: 10.1007/s002960050041 21. Nicu EA, Laine ML, Morre SA et al. Soluble CD14 in periodontitis. Innate Immun 2009;15:121-8. 
22. Guerra S, Carla Lohman I, LeVan TD et al. The differential effect of genetic variation on soluble CD14 levels in human plasma and milk. Am J Reprod Immunol 2004;52:204-11. DOI: 10.1111/j.1600-0897.2004.00207.x 23. LeVan TD, Guerra S, Klimecki W et al. The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes Immun 2006;7:77-80. DOI: 10.1038/sj.gene.6364276 
24. Koenig W, Khuseyinova N, Hoffmann MM et al. CD14 C(-260) – T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002;40:34-42. DOI: 10.1016/s0735-1097(02)01937-x 
25. LeVan TD, Michel O, Dentener M et al. Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation. J Allergy Clin Immunol 2008;121:434-40. DOI: 10.1016/j.jaci.2007.08.050 
26. Ted RM, Tricia D Levan, Harlan S et al. The Journal of Rheumatology 2011;38(12)2509-16. DOI: DOI:10.3899/jrheum.110378 
27. Midwood K, Sacre S, Piccinini AM et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009;15:774-80. 
28. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors. Nat Rev Rheumatol 2013;9:24-33. 
29. Ichise Y, Saegusa J, Tanaka-Natsui S et al. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4. Cells 2020;9(7):1689. DOI: 10.3390/cells9071689 30. Zvaifler NJ, Firestein GS. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 2024,37:783-9. DOI: 10.1002/art.1780370601

For citation: Kaliberdenko V.B., Petrov A.V., Gorlov A.A., Zagidullina E.R., Pronkina T.S., Gorbenko E.S., Bаchalova D.I., Batkaeva A.I. The role of CD14 in the pathogenesis of rheumatoid arthritis. Clinical review for general practice. 2025; 6 (6): 86–89 (In Russ.). DOI: 10.47407/kr2025.6.6.00635


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru